How Competitive Start Fund approval helped Nasal Medical lead the way in drug-free allergy prevention and relief

Martin O’Connell, founder, Nasal Medical

“Getting the Competitive Start Fund (CSF) approval validated what we were trying to do and gave us the confidence to grow.

Martin O’Connell, founder, Nasal Medical.

Key Takeouts:

  • 25% of Europeans suffer from a nose, chest or sinus allergy, a figure set to rise to 50% within a decade.
  • With support from Enterprise Ireland, including a Competitive Start Fund (CSF) investment in 2016, Nasal Medical’s Allergy Filter has revolutionised the drug-free allergy-prevention market.
  • Nasal Medical has a presence in the UK and will launch in the US in October. The company is working on a contract with one of the largest pharma companies in India and is exploring other markets in Europe with help from Enterprise Ireland.

Case Study: Nasal Medical

According to Allergy Ireland, about 25% of Europeans suffer from some sort of nose, chest or sinus allergy, a figure that’s set to rise to 50% within the next decade. While medical products can offer some relief, finding a long-term drug-free way to alleviate symptoms is high on the wish list of sufferers. With the help of several supports from Enterprise Ireland, including a Competitive Start Fund (CSF) investment in 2016, Nasal Medical has revolutionised the drug-free allergy-prevention market with its discreet and effective Allergy Filter.

“The ‘light bulb moment’ came through an unfortunate event on my family’s farm in Kerry,” explains founder Martin O’Connell, “when our cattle contracted tuberculosis I knew that I had to come up with a solution to prevent a reoccurrence, and from this, the concept for Nasal Medical, and a filter for humans, was born.”

How Nasal Medical secured CSF support“Nasal Medical specialises in anatomically designed nasal products to aid comfortable and effective breathing. Covering five target markets including pollution, allergies, sleeping disorders (mild sleep apnea and snoring), congestion and performance endurance, we address a myriad of major global problems – alleviating sleep disorders, protecting against the inhalation of seasonal allergies and contaminated air and enhancing athletic performance.

“We have launched two products so far, the Discreet Snoring Aid and the Allergy Nasal Filter, while the Travel Nasal Filter, Sports Aid, Pollution Filter and Snore Watch App will be launched in early 2020.”

The products are currently sold online, as well as in pharmacies in Ireland. “Google and eBay have been really helpful; we’re also recently selling through Amazon,” Martin explains. “We have a presence in the UK and will be expanding this soon along with our launch in the US in October. We’re also working on a contract with one of the largest pharma companies in India. In addition, we’re exploring other markets in Europe, with the help of Enterprise Ireland.”

 

How Nasal Medical secured CSF support

Martin and the team first approached Enterprise Ireland after developing a product prototype. From there, he was introduced to a development advisor in the High Potential Start-Ups (HPSU) unit, who helped the company to secure a feasibility grant and mentor in 2014, followed by a CSF investment in 2016.

“Aside from the funding, which has helped us in key areas of our business, the support and mentorship we have received as clients of Enterprise Ireland has been invaluable to us. They have opened doors for us, and connected us with people we could only dream of talking to.

The team in Enterprise Ireland has supported us every step of the way. We benefitted from advice and help from development advisors in the HPSU team and have also worked with the Eastpoint-based Market Research Centre, as well as overseas market advisors who took us to another level in export growth development.”

 

More than just funding

“The mentor Enterprise Ireland provided had huge experience in our sector, as well as great contacts. He was able to offer us first-hand advice and guidance and played an integral role in making sure that our patent protection and regulatory affairs were in order.

Following this, we were introduced to the team at SteriPack. Without them and without Enterprise Ireland, we probably wouldn’t be in existence today. The manufacturing side of the business was an obstacle for us, but the team at SteriPack were there to help us throughout the whole process. We have also received huge support from Eamonn Sayers in the Guinness Enterprise Centre, Chanelle, Lady McCoy, Pat Mullen of MSD Accountants, Dr. Paul Carson and John O’Dea.”

Being awarded the CSF in 2016 was a big turning point for the company. “Getting the CSF investment validated what we were trying to do and gave us the confidence to grow. The CSF also helped to get our product ready-to-sell, in terms of packaging, literature and finance for our first order.

“There’s a bit of work involved in applying, but that work will stand to you in the future – it will help you to develop a robust business plan, a detailed presentation, and iron out any issues, such as applying for patent protection and getting your finances and projections together. It will also help you to create a clear vision of your company for the future.”

 

Advice for companies planning to apply for future CSF calls

  • Martin’s advice is to get your business plan in place: “Know exactly where the money will be assigned within the business and make sure key areas are prioritised.”
  • Next: “Have a clear vision of what you want to achieve with the money, and where you want the company to be in five years’ time. If you don’t have much financial experience, you should speak with an accountant who will assist with the financial projections and P&Ls in the business plan.”
  • And: “Seek advice from someone who has been through the CSF process before.”

Enterprise Ireland is launching a new Competitive Start Fund on Tuesday 24th September 2019 (the call closes on Tuesday 8th October 2019 at 3pm). Aiming to support early stage start-ups, this CSF is open to early stage companies in manufacturing and internationally traded services.

Learn more about the Competitive Start Fund.

  • Share this article